Status:
COMPLETED
A Randomised Open Controlled Parallel Group Study Comparing Norspan and Tramadol
Lead Sponsor:
Mundipharma AB
Conditions:
Osteoarthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To evaluate the efficacy and safety of Norspan versus Tiperol Retard among OA patients who are sub-optimally treated with current analgesic. Those patients may benefit from treatment with a long lasti...
Eligibility Criteria
Inclusion
- OA diagnosis
- BS11 greater than or equal to 4 at base line
- Not adequately pain relieved with 4,000 mg paracetamol daily
Exclusion
- Treated with high potent opioids for their OA pain
- Treated with a regular dose for greater than one week of Tramadol, Codeine or dextropropoxifene during the last three months
- Other chronic conditions requiring frequent analgesic therapy
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2007
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00399178
Start Date
November 1 2006
End Date
June 1 2007
Last Update
August 17 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr Mats Karlsson
Falköping, Parkgatan 6C, Sweden, 521 43